|
|
Research progress of Chinese and western medicine in pulmonary rehabilitation of idiopathic pulmonary fibrosis |
LIN Qingqing1 LI Zhihui1 HONG Yunzhe1 YANG Shuguang2 YU Xueqing2▲ |
1.Henan University of Chinese Medicine/Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Coconstructed by Henan Province&Education Ministry of P.R.China Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan Province, Zhengzhou 450046, China; 2.Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Henan University of Chinese Medicine, Henan Province, Zhengzhou 450099, China
|
|
|
Abstract Idiopathic pulmonary fibrosis (IPF) is a refractory pulmonary disease. With the progress of the disease, the pulmonary function of the patients decreases progressively, which seriously affects the quality of life. Drug treatment has delayed the disease progression to a certain extent, and won more conditions and time windows for pulmonary rehabilitation treatment. Traditional Chinese and western medicine in pulmonary rehabilitation strategies such as exercise training, respiratory training, oxygen therapy, disease self-management, external treatment of traditional Chinese medicine and traditional Chinese medicine functional exercise can improve the exercise endurance, quality of life and reduce the risk after lung transplantation of IPF patients. However, there are still many problems to be further studied in IPF pulmonary rehabilitation. The article reviews the latest research progress of pulmonary rehabilitation in patients with IPF around the training methods and effect evaluation of pulmonary rehabilitation.
|
|
|
|
|
[1] Ley B,Collard HR,King TJ. Clinical course and prediction of survival in idiopathic pulmonary fibrosis [J]. Am J Respir Crit Care Med,2011,183(4):431-440.
[2] Raghu G,Collard HR,Egan JJ,et al. An official ATS/ERS/JRS/ ALAT statement:idiopathic pulmonary fibrosis:evidence- based guidelines for diagnosis and management [J]. Am J Res- pir Crit Care Med,2011,183(6):788-824.
[3] Spruit MA,Singh SJ,Garvey C,et al. An official American Thoracic Society/European Respiratory Society statement:key concepts and advances in pulmonary rehabilitation [J]. Am J Respir Crit Care Med,2013,188(8):e13-e64.
[4] Dowman L,Hill CJ,May A,et al. Pulmonary rehabilitation for interstitial lung disease [J]. Cochrane Database Syst Rev,2021,2(2):D6322.
[5] 刘西花,李晓旭,毕鸿雁,等.中医康复临床实践指南·心肺康复[J].康复学报,2020,30(4):259-265.
[6] Vainshelboim B,Oliveira J,Yehoshua L,et al. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis [J]. Respiration,2014,88(5):378-388.
[7] Jarosch I,Schneeberger T,Gloeckl R,et al. Short-Term Effects of Comprehensive Pulmonary Rehabilitation and its Maintenance in Patients with Idiopathic Pulmonary Fibrosis:A Randomized Controlled Trial [J]. J Clin Med,2020,9(5):1567.
[8] Arizono S,Taniguchi H,Sakamoto K,et al. Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis:comparison with chronic obstructive pulmonary disease [J]. Sarcoidosis Vasc Diffuse Lung Dis,2017,34(4):283-289.
[9] 赖德清,袁亚迪,谢晓梅,等.心肺康复运动训练对特发性肺间质纤维化患者心肺功能的影响研究[J].实用心脑肺血管病杂志,2021,29(10):86-91.
[10] 付延鑫,戴昂,董延春,等.肺康复对特发性肺纤维化疗效的meta分析[J].中国医药科学,2021,11(18):53-55.
[11] Vainshelboim B. Clinical Improvement and Effectiveness of Exercise-Based Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis:A Brief Analytical Review [J]. J Cardiopulm Rehabil Prev,2021,41(1):52-57.
[12] Lei S,Li X,Xie Y,et al. Clinical evidence for improving exercise tolerance and quality of life with pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis:A systematic review and meta-analysis [J]. Clin Rehabil,2022, 36(8):999-1015.
[13] Tzouvelekis A,Karampitsakos T,Kourtidou S,et al. Impact of Depression on Patients with Idiopathic Pulmonary Fibrosis [J]. Front Med (Lausanne),2020,7:29.
[14] 白辉辉,李彬,余学庆,等.运动肺康复治疗特发性肺间质纤维化合并焦虑抑郁临床研究[J].新中医,2019,51(4):140-142.
[15] Vainshelboim B,Oliveira J,Fox BD,et al. Long-term effects of a 12-week exercise training program on clinical out- comes in idiopathic pulmonary fibrosis [J]. Lung,2015,193(3):345-354.
[16] Nishiyama O,Kataoka K,Ando M,et al. Protocol for long- term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis [J]. ERJ Open Res,2021,7(3):00321-2021.
[17] Guler SA,Hur SA,Stickland MK,et al. Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease:a multicentre retrospective cohort study [J]. Thorax,2022,77(6):589-595.
[18] Nolan CM,Polgar O,Schofield SJ,et al. Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD:A Propensity-Matched Real-World Study [J]. Chest,2022, 161(3):728-737.
[19] Naranjo-Orellana J,Santalla A. Long-Term Combined Tra- ining in Idiopathic Pulmonary Fibrosis:A Case Study [J]. Int J Environ Res Public Health,2020,17(14):5091.
[20] 杨雪凝,李雪儿,王松,等.慢性阻塞性肺疾病患者呼吸肌训练的最佳证据总结[J].中华护理杂志,2022,57(1):49-55.
[21] Hoffman M. Inspiratory muscle training in interstitial lung disease:a systematic scoping review [J]. J Bras Pneumol,2021,47(4):e20210089.
[22] Hanada M,Kasawara KT,Mathur S,et al. Aerobic and breathing exercises improve dyspnea,exercise capacity and quality of life in idiopathic pulmonary fibrosis patients:systematic review and meta-analysis [J]. J Thorac Dis,2020, 12(3):1041-1055.
[23] Shen L,Zhang Y,Su Y,et al. New pulmonary rehabilitation exercise for pulmonary fibrosis to improve the pulmonary function and quality of life of patients with idiopathic pulmonary fibrosis:a randomized control trial [J]. Ann Palliat Med,2021,10(7):7289-7297.
[24] Jacobs SS,Krishnan JA,Lederer DJ,et al. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline [J]. Am J Respir Crit Care Med,2020,202(10):e121-e141.
[25] Arizono S,Furukawa T,Taniguchi H,et al. Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation [J]. Respirology,2020,25(11):1152- 1159.
[26] Badenes-Bonet D,Cejudo P,Rodó-Pin A,et al. Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis:a pilot crossover clinical trial [J]. BMC Pulm Med,2021,21(1):355.
[27] Kalluri M,Younus S,Archibald N,et al. Action plans in idiopathic pulmonary fibrosis:a qualitative study-’I do what I can do’[J]. BMJ Support Palliat Care,2021.
[28] Kalnins P,Brucker M,Spears D. Prolonged Survival in a Patient with Idiopathic Pulmonary Fibrosis Receiving Acupu- ncture and DHEA-Promoting Herbs with Conventional Management:A Case Report [J]. Perm J,2019,23:18-74.
[29] 周剑,吴炳辰.热敏灸联合药物对肺肾气虚型特发性肺纤维化患者肺功能及血清FGF-21、MMP-7的影响[J].上海针灸杂志,2021,40(2):152-156.
[30] 董怀洋,叶雨萌,李包娟,等.基于生物信息学和实验探究艾灸对肺纤维化的作用及其机制[J].中南药学,2022, 20(6):1217-1225.
[31] 荣宁,田伟峰.肺痿方离子导入对特发性肺纤维化患者肺功能及血清炎症因子的影响[J].中医药导报,2017, 23(11):112-114.
[32] 周彦吉,刘长信,蔡美玲,等.传统功法改善心肺功能系统评价的AMSTAR2质量评价及GRADE证据分级[J].国际中医中药杂志,2021,43(12):1272-1281.
[33] Zhou M,Zhang H,Li F,et al. Pulmonary Daoyin as a traditional Chinese medicine rehabilitation programme for patients with IPF:A randomized controlled trial [J]. Respirology,2021,26(4):360-369. |
|
|
|